Strata skin sciences, inc. (SSKN)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Cash Flows From Operating Activities:
Net loss

-3,790

-4,033

-21,514

-3,335

-24,947

-14,145

-25,948

-22,673

-20,384

-19,922

-18,452

Adjustments to reconcile net loss to net cash provided by operating activities:
Write-off of unamortized loan costs

-

-

-

-

-

-

983

-

-

-

-

Loss on disposal/abandonment of fixed assets

-

-

-

-

-

-

-

-

-

-

-20

Depreciation and amortization

4,503

5,397

6,336

6,366

4,051

1,790

2,439

970

562

552

314

Amount of amortization expense attributable to right-of-use asset from operating lease.

318

0

-

-

-

-

-

-

-

-

-

Provision for doubtful accounts

43

-30

109

120

20

52

-

-

-

-

-

Loss on disposal of property and equipment and lasers placed in service

0

-407

0

-124

0

16

-

-

-

-

-

Refers to gain (loss) on cancelation of distributor rights agreement.

0

11

40

0

-

-

-

-

-

-

-

The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of lasers placed-in-service to fair value.

30

194

196

0

-

-

-

-

-

-

-

Impairment of intangible assets

-

-

23

0

-

-

-

-

-

-

-

Impairment of long-lived assets

-

-

-

-

-

-

1,011

-

-

-

-

Bad debt expense

-

-

-

-

-

-

46

-

-

-

-

Write-off of unamortized financing costs

-

-

-

-

-

-

41

62

-

-

-

Issuance of common stock award

-

-

-

-

-

-

-

-

172

-

-

Stock-based compensation

1,195

904

186

113

1,753

413

1,301

1,488

3,183

727

826

Deferred taxes

-111

-303

55

240

119

0

-

-

-

-

-

Amount of amortization expense attributable to debt issuance costs and Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.

174

157

-

-

-

-

-

-

-

-

-

Loss on extinguishment of debentures

-

-

-20,160

0

-

-

-

-

-

-

-

Impairment of long-lived assets

-

-

-

-

920

0

-

-

-

-

-

Amortization of debt discount

-

-

944

2,473

8,479

1,943

0

-

-

-

-

Unrealized loss on marketable securities

-

-

-

-

-

-

-

-

-

-

-6

Amortization of deferred financing costs

-

-

188

200

391

191

250

-

-

23

103

Inventory write-offs

-

-

-

-

4,818

1,084

-

-

-

-

-

Change in fair value of warrant liability

-

-

-595

-5,396

-1,814

-

-

-

-

-

-

Change in fair value of embedded conversion feature

-

-

3,158

-

-

-

-

-

-

-

-

Change in fair value of warrant liability

-

-

-

-

-

8,103

-296

-

-

-

-

Inventory reserve

-

-

-

-

-

-

325

-

-

-

-

Gain on sale of fixed assets

-

-

-

-

-

-

0

-

-

-

-

Gain on sale of fixed assets

-

-

-

-

-

-

-

-

-

8

-

Changes in operating assets and liabilities:
Accounts receivable

1,036

222

-184

-558

186

215

-77

180

-

-

-

Inventories

233

-215

193

-1,311

508

784

-121

676

-

-

-

Amortization of discount on marketable securities

-

-

-

-

-

-

-

-

-

-

0

Prepaid expenses and other assets

-104

383

-475

-224

139

-606

-86

-96

537

-141

289

Accounts payable

116

-513

381

-2,605

-

-

-

-

-

-

-

Other assets

-

-

-

-

-

-

-36

20

248

289

2

Accounts payable and accrued expenses

-

-

-

-

542

-241

-484

1,390

-239

-121

311

Other accrued liabilities

634

1,006

602

-169

92

0

-

-

-

-

-

Other liabilities

-210

-60

159

36

-80

-46

27

10

1

-3

5

The increase (decrease) during the reporting period in the aggregate amount of lease liabilities that result from activities that generate operating income.

-241

0

-

-

-

-

-

-

-

-

-

Deferred revenues

733

171

-358

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-24

6

33

104

-

Deferred revenues

-

-

-

62

-81

-238

4

303

-

-

-36

Net cash provided by operating activities

2,229

2,896

4,140

322

-

-

-

-

-17,457

-18,820

-17,302

Cash Flows From Investing Activities:
Net cash provided by (used in) operating activities

-

-

-

-

-6,570

-17,709

-19,413

-19,224

-

-

-

The cash inflow (outflow) for Lasers placed in service.

2,676

1,749

1,739

1,008

1,689

-

-

-

-

-

-

Purchases of property and equipment

115

13

320

0

35

-17

-

-

-

-

-

Refers to cash outflows associated with the payments of distributor rights liability.

0

23

135

0

-

-

-

-

-

-

-

Proceeds from long-term debt

-

-

-

-

-

-

6,000

-

-

-

-

Expenses related to long-term debt

-

-

-

-

-

-

245

-

-

-

-

Expenses related to issuance of Series B convertible preferred stock

-

-

-

-

-

-

0

-

-

-

-

Net cash used in investing activities

-2,791

-1,785

-2,194

-868

-

-

-

-

-104

-1,033

-853

Cash Flows From Financing Activities:
Expenses related to financing

-

-

-

-

-

1,115

-

-

-

-

-

Proceeds from issuance of common stock

0

17,000

0

-

-

11,458

21,174

5,202

-

-

-

Acquisition costs, net of cash received

-

-

-

-125

42,500

0

-

-

-

-

-

Lasers placed-in-service, net

-

-

-

-

-

0

-

-

-

-

-

Restricted cash

-

-

-

-15

15

0

-

-

-

-

-

Proceeds from Public Offering

-

-

-

-

-

-

-

-

-

-

13,699

Offering costs

0

2,336

0

-

134

0

-

-

-

-

-

Purchases of property and equipment

-

-

-

-

-

-

5,188

6,158

104

1,044

1,251

Sale of marketable securities

-

-

-

-

-

-

-

-

-

-

397

Proceeds from the sale of fixed assets

-

-

-

-

-

-

0

-

-

10

-

Net cash used in investing activities

-

-

-

-

-44,239

17

-5,188

-6,158

-

-

-

Proceeds from convertible debentures

-

-

-

-

32,500

15,000

-

-

-

-

-

Repayment of convertible debentures

-

-

-

-

103

0

-

-

-

-

-

Proceeds from senior notes

-

-

-

-

10,000

0

-

-

-

-

-

Repayment of senior notes

-

-

-

-

10,000

0

-

-

-

-

-

Proceeds from long-term debt

-

-

-

1,500

10,500

0

-

-

-

-

-

Repayment of long-term debt

-

-

-

-

-

-

6,425

-

-

-

-

Repayments of long-term debt

7,571

3,000

1,429

0

-

-

-

-

-

-

-

Proceeds (payments) on notes payable

7,275

-357

-

-

-

-

-

-

-

-

-

Payments on notes payable

-

-

374

333

93

0

-

-

-

-

-

Proceeds from exercise of stock warrants

-

-

-

-

-

-

-

-

-

1,691

2,175

Net cash (used in) provided by financing activities

-296

11,307

-1,803

1,167

-

-

-

-

15,038

20,701

32,760

Net proceeds from private placements/public offerings

-

-

-

-

-

-

-

-

15,024

15,233

-

Net proceeds from Committed Equity Financing Facility

-

-

-

-

-

-

-

-

-

3,743

16,673

Proceeds from exercise of stock options

-

-

-

-

-

-

18

45

13

33

212

Net cash (used in ) provided by financing activities

-

-

-

-

42,670

25,343

20,522

5,247

-

-

-

Effect of exchange rate changes on cash

-

-

-2

4

8

0

-

-

-

-

-

Net (decrease) increase in cash and cash equivalents and restricted cash

-858

12,418

141

-

-

-

-

-

-

-

-

Net decrease in cash and cash equivalents

-

-

-

625

-8,131

7,651

-4,079

-20,135

-2,523

847

14,603

Supplemental information of cash and non-cash transactions:
Cash paid for interest

766

1,009

2,215

2,054

-

-

-

-

-

-

-

Cash paid for interest

-

-

-

-

1,188

116

0

41

-

-

-

Cash paid for income taxes

0

17

28

15

-

-

-

-

-

-

-

The cash inflow (outflow) for lease liabilities arising from obtaining right-of-use assets.

1,632

0

-

-

-

-

-

-

-

-

-

Modification of warrants recorded as a deemed dividend

-

-

-

-

2,962

0

-

-

-

-

-

Conversion of senior secured convertible debentures into common stock

-

-

262

265

4,815

-

-

-

-

-

-

Recognition of debt discount and beneficial conversion feature on long-term debt

-

-

-

-

27,300

10,353

-

-

-

-

-

Recognition of warrants issued with term note credit facility as debt discount

-

-

-

47

321

0

-

-

-

-

-

Prepaid insurance financed with notes payable

-

-

392

372

334

0

-

-

-

-

-

Recognition of debt discount on senior secured convertible debentures

-

-

-

-

-

-

0

-

-

-

-

Recognition of beneficial conversion feature on senior secured convertible debentures

-

-

-

-

-

-

0

-

-

-

-

Exchange of series A convertible preferred stock for series B convertible preferred stock

-

-

-

-

-

12,300

0

-

-

-

-

Recognition of warrants issued in connection with financings

-

-

-

-

2,958

5,585

-

-

-

-

-

Conversion of senior secured convertible debentures into common stock

-

-

-

-

-

1,589

0

-

-

-

-

Beneficial conversion feature recorded as a deemed dividend

-

-

-

-

-

1,887

-

-

-

-

-

Conversion of series A convertible preferred stock into common stock

-

-

-

-

-

513

0

-

-

-

-

Reclassification of MelaFind components from other assets to property and equipment

-

-

-

-

-

-

-

522

-

-

-

Reclassification of warrant liability to stockholders equity

-

-

-

-

-

-

652

-

-

-

-

Reclassification of property and equipment to inventory, net

-

-

-

-

107

0

5,402

-

-

-

-

Reclassification of warrant liabilities to equity

-

-

-

1,541

-5,399

0

-

-

-

-

-

The amount of debt that an entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. noncash is defined as transactions during a period that affect recognized asset and liabilities license.

-

-

286

0

-

-

-

-

-

-

-

Refers to issuance of convertible preferred stock in exchange for convertible debentures.

-

-

25,910

0

-

-

-

-

-

-

-